Dr. Maria Constantinou, MD

Dr. Constantinou practices at Rhode Island Hospital/Hasbro Children's in Providence, Rhode Island.

Dr. Constantinou's NPI, 1407999444, was assigned on February 15, 2007. Dr. Constantinou holds Rhode Island license MD10436.

Dr. Constantinou's primary practice is Rhode Island Hospital/Hasbro Children's, at 593 Eddy St, Providence, RI 02903 in Providence County. The practice phone is (401) 444-6966.

Dr. Constantinou's primary practice is Rhode Island Hospital/Hasbro Children's in Providence, Rhode Island. Dr. Constantinou is also affiliated with The Miriam Hospital. The medical group on file is Rhode Island Hospital. Dmand AI also links Dr. Constantinou to 2 more hospitals, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Constantinou practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Constantinou's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Constantinou is licensed in Rhode Island.

CMS data shows 369 Medicare services from Dr. Constantinou across 4 procedure codes in 2024, all of them office visits, for 162 Medicare patients. Medicare paid $29,322 for them.

CMS counts 162 Medicare patients who saw Dr. Constantinou in 2024. The largest group is 75 to 84, with 69 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Constantinou's median patient age at 73, with 69% women.

In 2024, Dr. Constantinou wrote 359 Medicare Part D claims for 116 patients. 91% of them were for generic drugs. CMS names the drug for 240 of them, across 10 drugs with 11 or more claims each, at $166,217 in total drug cost. In 2023, CMS named 275 claims across 9 drugs.

Dr. Constantinou accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Constantinou as offering telehealth.

Dmand AI links 4 papers to Dr. Constantinou, published from 2012 to 2020. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols. Dr. Constantinou has published most often in Am J Clin Oncol. Dr. Constantinou's most frequent co-authors are Kalyan C. Mantripragada, MD, David Berz, MD, MPH, PhD and Deus J. Cielo, MD.

Dmand AI links Dr. Constantinou to 4 clinical trials, 3 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Melanoma, Nevi and Melanomas and Carcinoma, Intraductal, Noninfiltrating. National Cancer Institute (NCI) sponsors the most, 3.

CMS Open Payments shows 20 general payments to Dr. Constantinou from 6 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 68% of the total. Bristol-Myers Squibb Company paid the most, $236.